Ignite Creation Date:
2025-12-24 @ 3:29 PM
Ignite Modification Date:
2026-01-02 @ 6:49 AM
Study NCT ID:
NCT04703192
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-09
First Post:
2021-01-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01)
Sponsor:
Daiichi Sankyo
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-03
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-02-19
Completion Date Type:
ESTIMATED
First Submit Date:
2021-01-07
First Submit QC Date:
None
Study First Post Date:
2021-01-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-05-10
Results First Submit QC Date:
None
Results First Post Date:
2024-07-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-02
Last Update Post Date:
2025-12-09
Last Update Post Date Type:
ESTIMATED